Vivani Medical (NASDAQ:VANI – Get Free Report) issued its earnings results on Monday. The company reported ($0.11) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.01), Zacks reports.
Vivani Medical Stock Performance
Shares of VANI opened at $1.05 on Tuesday. Vivani Medical has a twelve month low of $1.03 and a twelve month high of $2.22. The firm’s 50 day moving average price is $1.13 and its two-hundred day moving average price is $1.21. The firm has a market cap of $62.20 million, a P/E ratio of -2.33 and a beta of 3.20.
Analyst Upgrades and Downgrades
Separately, HC Wainwright restated a “buy” rating and issued a $4.00 price objective on shares of Vivani Medical in a research note on Wednesday, March 26th.
Vivani Medical Company Profile
Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
Further Reading
- Five stocks we like better than Vivani Medical
- Find and Profitably Trade Stocks at 52-Week Lows
- 5 Hot Stock Buys for Investors in April
- How to invest in marijuana stocks in 7 steps
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- How to Use Stock Screeners to Find Stocks
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
Receive News & Ratings for Vivani Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivani Medical and related companies with MarketBeat.com's FREE daily email newsletter.
